Since studies from our laboratory revealed that transcription-associated TOP1 K391 and K436 SUMOylation suppresses TOP1 activity while facilitating the TOP1–RNAPII interaction, it would be interesting to determine if TOP1 K391/K436 SUMO modification is deregulated in scleroderma. The gene discussed is TOP1; the disease is scleroderma.